Jazz Pharmaceuticals PLC (JAZZ)
125.10
+5.86
(+4.91%)
USD |
NASDAQ |
Nov 21, 16:00
126.97
+1.87
(+1.49%)
Pre-Market: 08:01
Jazz Pharmaceuticals Debt to Equity Ratio: 1.465 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.465 |
| June 30, 2024 | 1.517 |
| March 31, 2024 | 1.545 |
| December 31, 2023 | 1.529 |
| September 30, 2023 | 1.638 |
| June 30, 2023 | 1.622 |
| March 31, 2023 | 1.715 |
| December 31, 2022 | 1.855 |
| September 30, 2022 | 2.086 |
| June 30, 2022 | 1.881 |
| March 31, 2022 | 1.669 |
| December 31, 2021 | 1.526 |
| September 30, 2021 | 1.594 |
| June 30, 2021 | 1.631 |
| March 31, 2021 | 0.5534 |
| December 31, 2020 | 0.5724 |
| September 30, 2020 | 0.6182 |
| June 30, 2020 | 0.6694 |
| March 31, 2020 | 0.5734 |
| December 31, 2019 | 0.5166 |
| September 30, 2019 | 0.5252 |
| June 30, 2019 | 0.5367 |
| March 31, 2019 | 0.5855 |
| December 31, 2018 | 0.579 |
| September 30, 2018 | 0.5265 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.5546 |
| March 31, 2018 | 0.5678 |
| December 31, 2017 | 0.5827 |
| September 30, 2017 | 0.6398 |
| June 30, 2017 | 0.7596 |
| March 31, 2017 | 0.9454 |
| December 31, 2016 | 1.081 |
| September 30, 2016 | 1.272 |
| June 30, 2016 | 0.6967 |
| March 31, 2016 | 0.7366 |
| December 31, 2015 | 0.7434 |
| September 30, 2015 | 0.8249 |
| June 30, 2015 | 0.9445 |
| March 31, 2015 | 1.030 |
| December 31, 2014 | 0.9791 |
| September 30, 2014 | 1.000 |
| June 30, 2014 | 0.9349 |
| March 31, 2014 | 0.9597 |
| December 31, 2013 | 0.4245 |
| September 30, 2013 | 0.4431 |
| June 30, 2013 | 0.4699 |
| March 31, 2013 | 0.3883 |
| December 31, 2012 | 0.4074 |
| September 30, 2012 | 0.5218 |
| June 30, 2012 | 0.5628 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5166
Minimum
Dec 2019
2.086
Maximum
Sep 2022
1.339
Average
1.537
Median
Debt to Equity Ratio Benchmarks
| Avadel Pharmaceuticals PLC | 0.00 |
| Alkermes PLC | 0.2235 |
| Medtronic PLC | 0.5841 |
| Perrigo Co PLC | 1.041 |
| Iterum Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.26B |
| Total Liabilities (Quarterly) | 8.085B |
| Shareholders Equity (Quarterly) | 4.171B |
| Current Ratio | 4.263 |
| Net Debt Paydown Yield | -1.17% |